Skip to main content
Erschienen in: AIDS and Behavior 3/2018

13.06.2017 | Original Paper

Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States

verfasst von: Bryan Hartzler, Julia C. Dombrowski, Jason R. Williams, Heidi M. Crane, Joseph J. Eron, Elvin H. Geng, Christopher Mathews, Kenneth H. Mayer, Richard D. Moore, Michael J. Mugavero, Sonia Napravnik, Benigno Rodriguez, Dennis M. Donovan

Erschienen in: AIDS and Behavior | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Substance use disorders (SUDs) are thought to predict care discontinuity, though magnitude and substance-specific variance of effects are unclear. This report of analytic work undertaken with a multi-regional American cohort of 9153 care enrollees addresses these gaps. Care retention was computed from 24-month post-linkage clinic visit documentation, with SUD cases identified from patient-report screening instruments. Two generalized estimating equations tested binary and hierarchial SUD predictors of retention, and potential effect modification by patient age-group, sex, and care site. Findings demonstrate: (1) detrimental SUD effect, equivalent to a nine percentage-point decrease in retention, with independent effects of age-group and care site; (2) substance-specific effect of marijuana UD associated with lower retention; and (3) age-modification of each effect on care discontinuity, with SUDs serving as a risk factor among 18–29 year-olds and protective factor among 60+ year-olds. Collective findings document patient attributes as influences that place particular subgroups at-risk to discontinue care.
Literatur
1.
Zurück zum Zitat APA. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013. APA. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
2.
Zurück zum Zitat Hall HI, Holtgrave DR, Tang T, Rhodes P. HIV transmission in the United States: considerations of viral load, risk behavior, and health disparities. AIDS Behav. 2013;17:1632–6.CrossRefPubMed Hall HI, Holtgrave DR, Tang T, Rhodes P. HIV transmission in the United States: considerations of viral load, risk behavior, and health disparities. AIDS Behav. 2013;17:1632–6.CrossRefPubMed
3.
Zurück zum Zitat Dieffenbach WW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380–2.CrossRefPubMed Dieffenbach WW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380–2.CrossRefPubMed
4.
Zurück zum Zitat Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.CrossRefPubMed Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48–57.CrossRefPubMed
5.
Zurück zum Zitat Giordano TP, Visnegarwala F, White ACJ, Troisi CL, Frankowski RF, Hartman CM, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17(6):773–83.CrossRefPubMed Giordano TP, Visnegarwala F, White ACJ, Troisi CL, Frankowski RF, Hartman CM, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17(6):773–83.CrossRefPubMed
6.
Zurück zum Zitat Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentral Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Def Syndr. 2012;60:77–82.CrossRef Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Def Syndr. 2012;60:77–82.CrossRef
9.
Zurück zum Zitat Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48:248–56.CrossRefPubMedPubMedCentral Mugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48:248–56.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Rebeiro P, Althoff KN, Buchacz K, Gill J, Horberg M, Krentz H, et al. Retention among North American HIV-infected persons in clinical care, 2000-20008. J Acquir Immune Def Syndr. 2013;62(3):356–62.CrossRef Rebeiro P, Althoff KN, Buchacz K, Gill J, Horberg M, Krentz H, et al. Retention among North American HIV-infected persons in clinical care, 2000-20008. J Acquir Immune Def Syndr. 2013;62(3):356–62.CrossRef
11.
Zurück zum Zitat UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS, 2014 October. Report No.: Contract No.: UNAIDS/JC2684. UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS, 2014 October. Report No.: Contract No.: UNAIDS/JC2684.
13.
Zurück zum Zitat Mugavero MJ, Westfall AO, Zinski A, Davila J, Drainoni ML, Gardner LI, et al. Measuring retention in HIV care: the elusive gold standard. JAIDS. 2012;61(5):574–80.PubMedPubMedCentral Mugavero MJ, Westfall AO, Zinski A, Davila J, Drainoni ML, Gardner LI, et al. Measuring retention in HIV care: the elusive gold standard. JAIDS. 2012;61(5):574–80.PubMedPubMedCentral
14.
Zurück zum Zitat IOM. Monitoring HIV care in the United States: indicators and data systems. Washington, D.C.; 2012. IOM. Monitoring HIV care in the United States: indicators and data systems. Washington, D.C.; 2012.
15.
Zurück zum Zitat Dombrowski JC, Kitahata MM, Von Rompaey SE, Crane HM, Mugavero MJ, Eron JJ Jr, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. JAIDS. 2013;63(3):299–306.PubMedPubMedCentral Dombrowski JC, Kitahata MM, Von Rompaey SE, Crane HM, Mugavero MJ, Eron JJ Jr, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. JAIDS. 2013;63(3):299–306.PubMedPubMedCentral
16.
Zurück zum Zitat Hartzler B, Dombrowski JC, Crane HM, Eron JJ Jr, Geng EH, Mathews WC, et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017;21(4):1138–48.CrossRefPubMed Hartzler B, Dombrowski JC, Crane HM, Eron JJ Jr, Geng EH, Mathews WC, et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017;21(4):1138–48.CrossRefPubMed
17.
18.
Zurück zum Zitat Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDs. 2008;22(3):233–43.CrossRefPubMed Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDs. 2008;22(3):233–43.CrossRefPubMed
19.
Zurück zum Zitat Kitahata MM, Rodriquez B, Haubrick R, Boswell S, Mathews WC, Lederman MM, et al. Cohort profile: the centers for AIDS research network of integrated clinical systems. Int J Epidemiol. 2008;37:948–55.CrossRefPubMedPubMedCentral Kitahata MM, Rodriquez B, Haubrick R, Boswell S, Mathews WC, Lederman MM, et al. Cohort profile: the centers for AIDS research network of integrated clinical systems. Int J Epidemiol. 2008;37:948–55.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hughes MD. Initial treatment of HIV infection: randomized trials with clinical endpoints are still needed. J Infect Dis. 2006;194:542–4.CrossRefPubMed Hughes MD. Initial treatment of HIV infection: randomized trials with clinical endpoints are still needed. J Infect Dis. 2006;194:542–4.CrossRefPubMed
21.
Zurück zum Zitat Dawson DA, Smith SM, Saha TD, Rubinsky AD, Grant BF. Comparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders. Drug Alcohol Depend. 2012;126:384–8.CrossRefPubMedPubMedCentral Dawson DA, Smith SM, Saha TD, Rubinsky AD, Grant BF. Comparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders. Drug Alcohol Depend. 2012;126:384–8.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwuikarn J, et al. Validation of the alcohol, smoking, and substance involvement screening test (ASSIST). Addiction. 2008;103(6):1039–47.CrossRefPubMed Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwuikarn J, et al. Validation of the alcohol, smoking, and substance involvement screening test (ASSIST). Addiction. 2008;103(6):1039–47.CrossRefPubMed
23.
Zurück zum Zitat Mugavero MJ, Amico KR, Westfall AO, Crane HM, Zinski A, Willig JH, et al. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Def Syndr. 2012;59(1):86–93.CrossRef Mugavero MJ, Amico KR, Westfall AO, Crane HM, Zinski A, Willig JH, et al. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Def Syndr. 2012;59(1):86–93.CrossRef
24.
Zurück zum Zitat Hubbard AE, Ahern J, Fleischer NL, Van der Laan M, Lippman SA, Jewell N, et al. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology. 2010;21:467–74.CrossRefPubMed Hubbard AE, Ahern J, Fleischer NL, Van der Laan M, Lippman SA, Jewell N, et al. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology. 2010;21:467–74.CrossRefPubMed
25.
Zurück zum Zitat de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. JAIDS. 2005;38(1):43–6.PubMed de Jong BC, Prentiss D, McFarland W, Machekano R, Israelski DM. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. JAIDS. 2005;38(1):43–6.PubMed
26.
Zurück zum Zitat Fogarty A, Rowstorne P, Prestage G, Crawford J, Grierson J, Kippax S. Marijuana as therapy for people living with HIV/AIDS: social and health aspects. AIDS Care. 2007;19:295–307.CrossRefPubMed Fogarty A, Rowstorne P, Prestage G, Crawford J, Grierson J, Kippax S. Marijuana as therapy for people living with HIV/AIDS: social and health aspects. AIDS Care. 2007;19:295–307.CrossRefPubMed
27.
Zurück zum Zitat Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database Systematic Review. 2013;4(CD00517):5. Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database Systematic Review. 2013;4(CD00517):5.
28.
Zurück zum Zitat Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 2014;37:1–10.CrossRefPubMed Bonn-Miller MO, Oser ML, Bucossi MM, Trafton JA. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms. J Behav Med. 2014;37:1–10.CrossRefPubMed
29.
Zurück zum Zitat Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68:515–21.CrossRefPubMed Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68:515–21.CrossRefPubMed
30.
Zurück zum Zitat Mugavero MJ, Lin HY, Allison JJ, Willig JH, Chang PW, Marler M, et al. Failure to establish HIV care: characterizing the ‘no show’ phenomenon. Clin Infect Dis. 2007;45(1):127–30.CrossRefPubMed Mugavero MJ, Lin HY, Allison JJ, Willig JH, Chang PW, Marler M, et al. Failure to establish HIV care: characterizing the ‘no show’ phenomenon. Clin Infect Dis. 2007;45(1):127–30.CrossRefPubMed
31.
Zurück zum Zitat Catz SL, McClure JB, Jones GN, Brantley PJ. Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care. 1999;11:361–73.CrossRefPubMed Catz SL, McClure JB, Jones GN, Brantley PJ. Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care. 1999;11:361–73.CrossRefPubMed
32.
Zurück zum Zitat Israelski D, Gore-Felton C, Power R, Wood MJ, Koopman C. Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Prev Med. 2001;33:470–5.CrossRefPubMed Israelski D, Gore-Felton C, Power R, Wood MJ, Koopman C. Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Prev Med. 2001;33:470–5.CrossRefPubMed
33.
Zurück zum Zitat Oldenburg CE, Perez-Brumer AG, Reisner SL. Poverty matters: contextualizing the syndemic condition of psychological factors and newly diagnosed HIV infection in the United States. AIDS. 2014;28(18):2763–9.CrossRefPubMedPubMedCentral Oldenburg CE, Perez-Brumer AG, Reisner SL. Poverty matters: contextualizing the syndemic condition of psychological factors and newly diagnosed HIV infection in the United States. AIDS. 2014;28(18):2763–9.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Def Syndr. 2007;44(2):159–66.CrossRef Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Def Syndr. 2007;44(2):159–66.CrossRef
35.
Zurück zum Zitat Kalichman SC, Sikkema KJ, DiFonzo K, Luke W, Austin J. Emotional adjustment in survivors of sexual assault living with HIV-AIDS. J Trauma Stress. 2002;15(4):286–96.CrossRef Kalichman SC, Sikkema KJ, DiFonzo K, Luke W, Austin J. Emotional adjustment in survivors of sexual assault living with HIV-AIDS. J Trauma Stress. 2002;15(4):286–96.CrossRef
36.
Zurück zum Zitat Parsons JT, Rosof E, Punzalan JC, Di Maria L. Integration of Motivational Interviewing and Cognitive Behavioral Therapy to Improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care STDs. 2005;19(1):31–9.CrossRefPubMed Parsons JT, Rosof E, Punzalan JC, Di Maria L. Integration of Motivational Interviewing and Cognitive Behavioral Therapy to Improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care STDs. 2005;19(1):31–9.CrossRefPubMed
37.
Zurück zum Zitat Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.CrossRefPubMedPubMedCentral Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Petry NM, Weinstock J, Alessi SM, Lewis MW, Dieckhaus K. Group-based randomized trial of contingencies for health and abstinence in HIV patients. J Consult Clin Psychol. 2010;78(1):89–97.CrossRefPubMedPubMedCentral Petry NM, Weinstock J, Alessi SM, Lewis MW, Dieckhaus K. Group-based randomized trial of contingencies for health and abstinence in HIV patients. J Consult Clin Psychol. 2010;78(1):89–97.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Rosen MI, Dieckhaus K, McMahon TJ, Valdes B, Petry N, Cramer JA, et al. Improved adherence with contingency management. AIDS Patient Care STDs. 2007;21(1):30–40.CrossRefPubMed Rosen MI, Dieckhaus K, McMahon TJ, Valdes B, Petry N, Cramer JA, et al. Improved adherence with contingency management. AIDS Patient Care STDs. 2007;21(1):30–40.CrossRefPubMed
40.
Zurück zum Zitat Diiorio C, McCarty F, Resnicow K, McDonnell-Holstad M, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.CrossRefPubMedPubMedCentral Diiorio C, McCarty F, Resnicow K, McDonnell-Holstad M, Soet J, Yeager K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42(1):42–51.CrossRefPubMedPubMedCentral Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42(1):42–51.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat NIDA. Principles of drug addiction treatment: a research-based guide (3rd ed.). Services USDoHaH, editor2012. NIDA. Principles of drug addiction treatment: a research-based guide (3rd ed.). Services USDoHaH, editor2012.
43.
Zurück zum Zitat Rapp RC, Van Den Noortgate W, Broekaert E, Vanderplasschen W. The efficacy of case management with persons who have substance abuse problems: a three-level met-analysis of outcomes. J Consult Clin Psychol. 2014;82(4):605–18.CrossRefPubMed Rapp RC, Van Den Noortgate W, Broekaert E, Vanderplasschen W. The efficacy of case management with persons who have substance abuse problems: a three-level met-analysis of outcomes. J Consult Clin Psychol. 2014;82(4):605–18.CrossRefPubMed
Metadaten
Titel
Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States
verfasst von
Bryan Hartzler
Julia C. Dombrowski
Jason R. Williams
Heidi M. Crane
Joseph J. Eron
Elvin H. Geng
Christopher Mathews
Kenneth H. Mayer
Richard D. Moore
Michael J. Mugavero
Sonia Napravnik
Benigno Rodriguez
Dennis M. Donovan
Publikationsdatum
13.06.2017
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 3/2018
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1826-2

Weitere Artikel der Ausgabe 3/2018

AIDS and Behavior 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.